Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity

NCT06820099 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Adults With Heart Failure, Mild Decrease in Ejection Fraction/Preserved Ejection Fraction, and Obesity

Interventions

DRUG: HRS-7535 tablet
DRUG: HRS-7535 tablet placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.